Powder Pharms Drug Patent Portfolio
Powder Pharms owns 1 orange book drug protected by 7 US patents Given below is the list of Powder Pharms's drug patents along with their expiration dates.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US9370622 | Devices and methods for delivering particles | 28 Sep, 2035 | Active |
US9358338 | Particle cassettes and processes therefor | 27 Apr, 2035 | Active |
US8540665 | Particle cassettes and processes therefor | 22 Oct, 2029 | Active |
US6004286 | Particle delivery | 17 Mar, 2017 | Expired |
US6881200 | Needleless syringe using super sonic gas flow for particle delivery | 11 Jun, 2016 | Expired |
US5899880 | Needleless syringe using supersonic gas flow for particle delivery | 04 May, 2016 | Expired |
US5630796 | Method of delivering powder transdermally with needless injector | 20 May, 2014 | Expired |
Latest Legal Activities on Powder Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Powder Pharms.
Activity | Date | Patent Number |
---|---|---|
Maintenance Fee Reminder Mailed
Critical
| 12 Feb, 2024 | US9370622 |
Payment of Maintenance Fee, 8th Yr, Small Entity | 05 Mar, 2021 | US8540665 |
Payment of Maintenance Fee, 4th Yr, Small Entity | 03 Jul, 2019 | US9370622 |
Recordation of Patent Grant Mailed
Critical
| 21 Jun, 2016 | US9370622 |
Patent Issue Date Used in PTA Calculation
Critical
| 21 Jun, 2016 | US9370622 |
Issue Notification Mailed
Critical
| 01 Jun, 2016 | US9370622 |
Dispatch to FDC | 24 May, 2016 | US9370622 |
Application Is Considered Ready for Issue
Critical
| 20 May, 2016 | US9370622 |
Issue Fee Payment Verified
Critical
| 20 May, 2016 | US9370622 |
Issue Fee Payment Received
Critical
| 20 May, 2016 | US9370622 |
Mail Response to 312 Amendment (PTO-271)
Critical
| 07 Apr, 2016 | US9370622 |
Printer Rush- No mailing | 06 Apr, 2016 | US9370622 |
Response to Amendment under Rule 312
Critical
| 06 Apr, 2016 | US9370622 |
Pubs Case Remand to TC
Critical
| 04 Apr, 2016 | US9370622 |
Amendment after Notice of Allowance (Rule 312)
Critical
| 01 Apr, 2016 | US9370622 |
Powder Pharms's Family Patents
Powder Pharms Drug List
Given below is the complete list of Powder Pharms's drugs and the patents protecting them.
1. Zingo
Zingo is protected by 7 patents, out of which 4 have expired. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US9370622 | Devices and methods for delivering particles |
28 Sep, 2035
(10 years from now)
| Active |
US9358338 | Particle cassettes and processes therefor |
27 Apr, 2035
(10 years from now)
| Active |
US8540665 | Particle cassettes and processes therefor |
22 Oct, 2029
(4 years from now)
| Active |
US6004286 | Particle delivery |
17 Mar, 2017
(7 years ago)
| Expired |
US6881200 | Needleless syringe using super sonic gas flow for particle delivery |
11 Jun, 2016
(8 years ago)
| Expired |
US5899880 | Needleless syringe using supersonic gas flow for particle delivery |
04 May, 2016
(8 years ago)
| Expired |
US5630796 | Method of delivering powder transdermally with needless injector |
20 May, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zingo's drug page